Covid-19 vaccines are poised to become big business. Its potential to generate staggering revenue has already added billions of dollars to the market value of drug makers like Pfizer and Moderna. . That promise is also drawing scrutiny in Washington. Rising prescription drug costs are one of the few problems …
Read More »
Covid-19 vaccines are poised to become big business. Its potential to generate staggering revenue has already added billions of dollars to the market value of drug makers like Pfizer and Moderna.. That promise is also drawing scrutiny in Washington. Rising prescription drug costs are one of the few problems where …
Read More »
The United States will pay the pharmaceutical company Pfizer $ 1.95 billion to produce and deliver 100 million doses of the company’s COVID-19 vaccine candidate in case the drug is effective in human trials, the company said in a press release on Wednesday. Pfizer will administer the vaccine when the …
Read More »
AstraZeneca Plc fell from a record in New York trade after data for the company’s Covid-19 vaccine candidate, while promising, fueled concerns about whether it can match competitors. Bernstein analysts led by Ronny Gal said the vaccine, developed in association with the University of Oxford, showed initial positive data, but …
Read More »
German vaccine maker CureVac has lost some shine in the race for a COVID-19 vaccine after other mRNA-based applicants have caught the attention of regulators. Still, CureVac is reported to have caught a great partner to help build its game-changing RNA “printers” that could turn global interest in its favor. …
Read More »